Clinical implications of proximal tubular multicilia in glomerular diseases

Introduction: Multiciliated cells (MCCs) have been identified in the proximal tubules of patients with kidney disease; however, their clinical significance is unknown. We aimed to investigate whether MCCs are associated with clinical outcomes in patients with glomerular diseases. Methods: Between Au...

Full description

Saved in:
Bibliographic Details
Main Authors: Bohye Kim, Boram Weon, Evonne Kim, Sohee Park, Wencheng Jin, Nayeon Shin, Yun Kyu Oh, Chun Soo Lim, Jung Pyo Lee, Obin Kwon, Jeonghwan Lee
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025007960
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087564382633984
author Bohye Kim
Boram Weon
Evonne Kim
Sohee Park
Wencheng Jin
Nayeon Shin
Yun Kyu Oh
Chun Soo Lim
Jung Pyo Lee
Obin Kwon
Jeonghwan Lee
author_facet Bohye Kim
Boram Weon
Evonne Kim
Sohee Park
Wencheng Jin
Nayeon Shin
Yun Kyu Oh
Chun Soo Lim
Jung Pyo Lee
Obin Kwon
Jeonghwan Lee
author_sort Bohye Kim
collection DOAJ
description Introduction: Multiciliated cells (MCCs) have been identified in the proximal tubules of patients with kidney disease; however, their clinical significance is unknown. We aimed to investigate whether MCCs are associated with clinical outcomes in patients with glomerular diseases. Methods: Between August 2012 and April 2021, 134 patients (including 126 with glomerular disease patients and 8 controls) who were hospitalized at Seoul National University Boramae Medical Center and Seoul National University Hospital were included in this study. The ratio of MCCs to total proximal tubular cells was calculated using immunohistochemistry. The relationship between the MCC ratio and kidney disease-related clinical features was then analyzed. Results: MCCs were exclusively detected in patients with glomerular diseases (68.3 %), not those in the control group. Patients with diabetic kidney disease (88.9 %) or antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN, 86.4 %) had higher MCC ratios. MCC-positivity and MCC ratios were significantly associated with increased age and proteinuria, and a decreased estimated glomerular filtration rate (eGFR). Patients with higher MCC ratios had a significantly higher risk of end-stage kidney disease (ESKD) and composite outcomes with death. In multivariable analysis, MCC ratios were significantly correlated with an increased risk of ESKD (hazard ratio [HR], 1.413; 95 % confidence interval [CI], 1.012–1.972) and composite outcome (HR, 1.401; 95 % CI, 1.028–1.909). Conclusion: Higher MCC ratios were correlated with poorer prognosis; therefore, quantification of MCCs in the proximal tubules can serve as a valuable prognostic marker in clinical practice.
format Article
id doaj-art-a5821dd2f4b340d3b0454ee65e98f780
institution Kabale University
issn 2405-8440
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-a5821dd2f4b340d3b0454ee65e98f7802025-02-06T05:12:36ZengElsevierHeliyon2405-84402025-02-01113e42416Clinical implications of proximal tubular multicilia in glomerular diseasesBohye Kim0Boram Weon1Evonne Kim2Sohee Park3Wencheng Jin4Nayeon Shin5Yun Kyu Oh6Chun Soo Lim7Jung Pyo Lee8Obin Kwon9Jeonghwan Lee10Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, South KoreaDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South KoreaDepartment of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea; Department of Biomedical Sciences, BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea; Department of Biomedical Sciences, BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South KoreaDepartment of Internal Medicine, College of Medicine, Seoul National University, Seoul, South KoreaDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South KoreaDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South KoreaDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South KoreaDepartment of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, South Korea; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, South Korea; Department of Biomedical Sciences, BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine, Seoul, South Korea; Sensory Organ Research Institute, Medical Research Center, Seoul National University, Seoul, South Korea; Corresponding author. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, South Korea; Corresponding author. Department of Internal Medicine, Seoul National University Boramae Medical Center, Boramae Medical Center, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul, 07061, South Korea.Introduction: Multiciliated cells (MCCs) have been identified in the proximal tubules of patients with kidney disease; however, their clinical significance is unknown. We aimed to investigate whether MCCs are associated with clinical outcomes in patients with glomerular diseases. Methods: Between August 2012 and April 2021, 134 patients (including 126 with glomerular disease patients and 8 controls) who were hospitalized at Seoul National University Boramae Medical Center and Seoul National University Hospital were included in this study. The ratio of MCCs to total proximal tubular cells was calculated using immunohistochemistry. The relationship between the MCC ratio and kidney disease-related clinical features was then analyzed. Results: MCCs were exclusively detected in patients with glomerular diseases (68.3 %), not those in the control group. Patients with diabetic kidney disease (88.9 %) or antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN, 86.4 %) had higher MCC ratios. MCC-positivity and MCC ratios were significantly associated with increased age and proteinuria, and a decreased estimated glomerular filtration rate (eGFR). Patients with higher MCC ratios had a significantly higher risk of end-stage kidney disease (ESKD) and composite outcomes with death. In multivariable analysis, MCC ratios were significantly correlated with an increased risk of ESKD (hazard ratio [HR], 1.413; 95 % confidence interval [CI], 1.012–1.972) and composite outcome (HR, 1.401; 95 % CI, 1.028–1.909). Conclusion: Higher MCC ratios were correlated with poorer prognosis; therefore, quantification of MCCs in the proximal tubules can serve as a valuable prognostic marker in clinical practice.http://www.sciencedirect.com/science/article/pii/S2405844025007960GlomerulonephritisDiabetic kidney diseaseMulticiliated cellsProteinuriaEstimated glomerular filtration rateEnd-stage kidney disease
spellingShingle Bohye Kim
Boram Weon
Evonne Kim
Sohee Park
Wencheng Jin
Nayeon Shin
Yun Kyu Oh
Chun Soo Lim
Jung Pyo Lee
Obin Kwon
Jeonghwan Lee
Clinical implications of proximal tubular multicilia in glomerular diseases
Heliyon
Glomerulonephritis
Diabetic kidney disease
Multiciliated cells
Proteinuria
Estimated glomerular filtration rate
End-stage kidney disease
title Clinical implications of proximal tubular multicilia in glomerular diseases
title_full Clinical implications of proximal tubular multicilia in glomerular diseases
title_fullStr Clinical implications of proximal tubular multicilia in glomerular diseases
title_full_unstemmed Clinical implications of proximal tubular multicilia in glomerular diseases
title_short Clinical implications of proximal tubular multicilia in glomerular diseases
title_sort clinical implications of proximal tubular multicilia in glomerular diseases
topic Glomerulonephritis
Diabetic kidney disease
Multiciliated cells
Proteinuria
Estimated glomerular filtration rate
End-stage kidney disease
url http://www.sciencedirect.com/science/article/pii/S2405844025007960
work_keys_str_mv AT bohyekim clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT boramweon clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT evonnekim clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT soheepark clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT wenchengjin clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT nayeonshin clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT yunkyuoh clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT chunsoolim clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT jungpyolee clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT obinkwon clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases
AT jeonghwanlee clinicalimplicationsofproximaltubularmulticiliainglomerulardiseases